Direktorat Registrasi ObatValid

OZEMPIC

BPOM Number: DKI2164605043A1
Approved: 4 September 2025
Expiry: 3 September 2030
Form: LARUTAN INJEKSI

About This Registration

OZEMPIC is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2164605043A1. Its current registration status is Valid, with the licence valid until 3 September 2030. The product is registered to BETA PHARMACON - INDONESIA. BPOM first approved this registration in September 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 CARTRIDGE @ 3 ML IN PRE-FILLED PEN (1 MG/DOSIS) + 4 JARUM NOVOFINE PLUS
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

BETA PHARMACON - INDONESIA
KAB. KARAWANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

BETA PHARMACON - INDONESIA
KAB. KARAWANG
primary
View profile →

Ingredients (1)

SEMAGLUTIDE

Market Intelligence

Owner Portfolio: BETA PHARMACON - INDONESIA holds 76 BPOM registrations
Manufacturer Scale: BETA PHARMACON - INDONESIA produces 76 registered products
Registration Age: Registered for 10 months

FDA Cross-Reference

via openFDA

Generic Name: ORAL SEMAGLUTIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?